Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
1.890
-0.030 (-1.56%)
At close: Feb 20, 2026, 4:00 PM EST
1.920
+0.030 (1.59%)
After-hours: Feb 20, 2026, 7:27 PM EST
Treace Medical Concepts Market Cap
Treace Medical Concepts has a market cap or net worth of $120.43 million as of February 20, 2026. Its market cap has decreased by -81.66% in one year.
Market Cap
120.43M
Enterprise Value
133.38M
1-Year Change
-81.66%
Ranking
Category
Stock Price
$1.89
Market Cap Chart
Since the IPO on April 23, 2021, Treace Medical Concepts's market cap has decreased from $889.74M to $120.43M, a decrease of -86.46%. That is a compound annual growth rate of -33.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 120.43M | -22.86% |
| Dec 31, 2025 | 156.11M | -66.32% |
| Dec 31, 2024 | 463.49M | -41.06% |
| Dec 29, 2023 | 786.37M | -38.37% |
| Dec 30, 2022 | 1.28B | 28.74% |
| Dec 31, 2021 | 991.14M | 11.40% |
| Apr 23, 2021 | 889.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nano-X Imaging | 168.18M |
| InfuSystem Holdings | 160.25M |
| Inogen | 158.28M |
| Apyx Medical | 150.37M |
| CVRx, Inc. | 144.71M |
| LENSAR | 135.33M |
| AVITA Medical | 131.72M |
| Hyperfine | 111.74M |